Laboratory Question for the Week of May 6, 2019
I have heard that the FDA will begin to regulate lab-developed tests (LDTs). Can you provide any information about this?
I have heard that the FDA will begin to regulate lab-developed tests (LDTs). Can you provide any information about this?
What are the four new PLA codes released in April 2019?
Has CMS added any diagnosis code lately to the list of codes covered by Medicare for the thyroid testing national coverage determination (NCD)?
Can modifier 59 be assigned to both column-one and column-two codes listed in the procedure-to-procedure edits?
What code would I report if a complete blood count (CBC) was ordered with no mention of a differential?
Did the Centers for Medicare and Medicaid Services (CMS) recently eliminate a modifier used for laboratory tests?
When would codes 88000–88099 be reported?
What does the modifier XU stand for?
What are the key criteria behind the CMS and CDC CLIA proposed changes to the addition of analytes for non-microbiology specialties?
What fees are impacted by CLIA 20-percent increase?
How has quality measure Q397 been revised?
Is the performing laboratory required to bill Medicare for the test if all conditions of the new laboratory DOS exception are met?
CPT® copyright 2025 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
BLOOM INTO SAVINGS! Get 25% OFF during our spring sale through March 27. Use code SPRING26Â at checkout to claim this offer.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24Â